Genome editing offers a practical and scalable approach to address biological and economic challenges in aquaculture by enabling precise variations of high-value traits.
This presentation outlines a trait-focused framework for applying genome editing across aquaculture species at commercial-scale production, demonstrating its potential to deliver measurable gains throughout the production chain. Priority traits include yield, growth rate, sterility, and disease resistance. Quantitative economic modelling illustrates how enhancing these traits can generate substantial upstream and downstream value while improving farm-level efficiency, survival, and biomass output. This improves the environmental sustainability of aquaculture while also providing consumers with greater access to a healthy source of protein.
A central component of this work is the operational capacity required to perform genome editing at a commercial scale, including mobile laboratory infrastructure and high-throughput microinjection capabilities that can process up to 30,000 salmon ova or 25,000 tilapia eggs within commercially viable timescales. Our work shows that genome editing has moved beyond proof-of-concept and is now a commercially operational tool capable of generating genetic and economic gains within one generation.
We also present strategies for integrating genome-edited animals into breeding nuclei. Sharing scenarios across different species, incorporating varying editing efficiencies, inbreeding levels, and trait improvements, we demonstrate that genome editing introduces beneficial genetic variation with accuracy and speed, achieving results in one generation that could take decades with traditional selective breeding.
These results establish genome editing as a high-impact tool for accelerating genetic improvement, improving food availability, and driving sustainability and resilience in global aquaculture.